Stretch Mark Treatment Mountain View

Palomar Lux 1540 laser receives first FDA approval for treatment of stretch marks

The Palomar Lux 1540 has received the first and only FDA clearance for the treatment of stretch marks. Patients received 50-75% or greater improvement in the appearance of their stretch marks. The great advantage of the Lux 1540 is that it can be used on all skin types, and all kinds of stretch marks. Stretch marks can be white, or red, or pigmented. It works on all of them, without the risk of long-lasting PIH, post-inflammatory hyperpigmentation. Previous lasers, and intense pulsed-light attempts at stretch mark removal were very likely to cause PIH, especially in darker skin types. The Lux 1540 can be used for all skin types, I-VI, which means Hispanic, Asian and African-American patients can receive the same treatment with no increased risk.

We usually recommend three treatments, but improvements have been seen in only one treatment. For details, click on the link to the “white paper” below, which has some interesting data and photographs.

Both women and men are afflicted with this complaint. We see them on the inner arms, the breasts, the abdomen, flanks, and thighs, practically anywhere the skin has been subject to some stretching. Some people get them who have never gained and lost weight, particularly on the innner arms.

So give us a call and see if we can help you with the first FDA-approved treatment for stretch marks.

Palomar Medical Technologies, Inc. Receives First FDA Clearance for Fractional Laser Treatment of Striae

Palomar is pleased to announce that the Lux1540™ Fractional non-ablative laser has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretchmarks) using a fractional laser. This new clearance will allow aesthetic practitioners to treat the millions of women in the United States with unwanted stretchmarks by offering long-lasting, superior results.

Ongoing clinical studies have shown that subjects treated with the Lux1540 Fractional non-ablative laser achieved an average improvement of between 51% and 75% in the appearance of their stretchmarks.

This new clearance expands the broad range of treatments offered by the Lux1540, which may be used to treat surgical scars, acne scars, and melasma, as well as offer non-ablative skin resurfacing.

To learn more about the treatment of striae with the Lux1540 Fractional non-ablative laser, download this paper.

http://www.ncbi.nlm.nih.gov/pubmed?term=de%20angelis%2C%20Striae